Mortality attributable to diabetes in 20-79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 11 02 2020
accepted: 12 02 2020
pubmed: 19 2 2020
medline: 15 7 2020
entrez: 19 2 2020
Statut: ppublish

Résumé

To estimate the number of deaths attributable to diabetes in 20-79-year-old adults in 2019. The following were used to estimate the number of deaths attributable to diabetes: all-cause mortality estimates from the World Health Organization life table, country level age- and sex-specific estimates of diabetes prevalence in 2019 and relative risks of death in people with diabetes compared to people without diabetes. An estimated 4.2 million deaths among 20-79-year-old adults are attributable to diabetes. Diabetes is estimated to contribute to 11.3% of deaths globally, ranging from 6.8% (lowest) in the Africa Region to 16.2% (highest) in the Middle East and North Africa. About half (46.2%) of the deaths attributable to diabetes occur in people under the age of 60 years. The Africa Region has the highest (73.1%) proportion of deaths attributable to diabetes in people under the age of 60 years, while the Europe Region has the lowest (31.4%). Diabetes is estimated to contribute to one in nine deaths among adults aged 20-79 years. Prevention of diabetes and its complications is essential, particularly in middle-income countries, where the current impact is estimated to be the largest. Contemporary data from diverse populations are needed to validate these estimates.

Identifiants

pubmed: 32068099
pii: S0168-8227(20)30139-X
doi: 10.1016/j.diabres.2020.108086
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108086

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Pouya Saeedi (P)

International Diabetes Federation, Brussels, Belgium. Electronic address: pouya.saeedi@idf.org.

Paraskevi Salpea (P)

International Diabetes Federation, Brussels, Belgium.

Suvi Karuranga (S)

International Diabetes Federation, Brussels, Belgium.

Inga Petersohn (I)

International Diabetes Federation, Brussels, Belgium.

Belma Malanda (B)

International Diabetes Federation, Brussels, Belgium.

Edward W Gregg (EW)

School of Public Health, Imperial College London, United Kingdom.

Nigel Unwin (N)

MRC Epidemiology Unit, University of Cambridge, United Kingdom.

Sarah H Wild (SH)

Centre for Population Health Sciences, Usher Institute, University of Edinburgh, United Kingdom.

Rhys Williams (R)

Diabetes Research Unit Cymru, Swansea University, Swansea, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH